Pregled bibliografske jedinice broj: 1057072
COVID-19 - is the ACE2 just a foe?
COVID-19 - is the ACE2 just a foe? // American journal of physiology. Lung cellular and molecular physiology, 318 (2020), 5; L1025-L1026 doi:10.1152/ajplung.00119.2020 (međunarodna recenzija, pismo uredniku, znanstveni)
CROSBI ID: 1057072 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
COVID-19 - is the ACE2 just a foe?
Autori
Jakovac, Hrvoje
Izvornik
American journal of physiology. Lung cellular and molecular physiology (1040-0605) 318
(2020), 5;
L1025-L1026
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pismo uredniku, znanstveni
Ključne riječi
COVID-19 ; ACE2 ; RAS ; SARS-CoV-2 ; lung injury
(COVID-19 ; ACE2 ; RAS ; SARS-Cov-2 ; lung injury)
Sažetak
I read with great interest and pleasure the recent editorial article "Covid-19 infection 31 and mortality – A physiologist's perspective enlightening clinical features and plausible interventional 32 strategies" by Abassi ZA and colleagues (1). In the article, the authors suggested blockage of 33 angiotensin-converting enzyme 2 (ACE2) as a potential strategy for mitigating clinical picture and 34 reducing mortality in SARS-CoV-2 infected subjects
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
